Hercules Capital ROA 2010-2024 | HTGC
Current and historical return on assets (ROA) values for Hercules Capital (HTGC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Hercules Capital ROA - Return on Assets Historical Data |
Date |
TTM Net Income |
Total Assets |
Return on Assets |
2024-09-30 |
$0.32B |
$3.66B |
8.92% |
2024-06-30 |
$0.28B |
$3.67B |
7.96% |
2024-03-31 |
$0.33B |
$3.70B |
9.77% |
2023-12-31 |
$0.34B |
$3.42B |
10.22% |
2023-09-30 |
$0.28B |
$3.34B |
8.75% |
2023-06-30 |
$0.31B |
$3.23B |
9.85% |
2023-03-31 |
$0.20B |
$3.25B |
6.66% |
2022-12-31 |
$0.10B |
$3.03B |
3.58% |
2022-09-30 |
$0.04B |
$2.93B |
1.59% |
2022-06-30 |
$0.02B |
$2.87B |
0.55% |
2022-03-31 |
$0.11B |
$2.69B |
4.05% |
2021-12-31 |
$0.18B |
$2.60B |
6.63% |
2021-09-30 |
$0.32B |
$2.79B |
12.18% |
2021-06-30 |
$0.34B |
$2.58B |
13.25% |
2021-03-31 |
$0.32B |
$2.58B |
12.57% |
2020-12-31 |
$0.23B |
$2.62B |
9.09% |
2020-09-30 |
$0.12B |
$2.50B |
4.92% |
2020-06-30 |
$0.10B |
$2.47B |
4.02% |
2020-03-31 |
$0.08B |
$2.40B |
3.50% |
2019-12-31 |
$0.17B |
$2.46B |
7.50% |
2019-09-30 |
$0.11B |
$2.32B |
5.10% |
2019-06-30 |
$0.13B |
$2.31B |
6.18% |
2019-03-31 |
$0.13B |
$2.14B |
6.81% |
2018-12-31 |
$0.08B |
$1.95B |
4.23% |
2018-09-30 |
$0.11B |
$1.82B |
6.44% |
2018-06-30 |
$0.11B |
$1.79B |
6.56% |
2018-03-31 |
$0.09B |
$1.62B |
5.58% |
2017-12-31 |
$0.08B |
$1.66B |
4.87% |
2017-09-30 |
$0.07B |
$1.58B |
4.76% |
2017-06-30 |
$0.07B |
$1.59B |
4.69% |
2017-03-31 |
$0.05B |
$1.59B |
3.21% |
2016-12-31 |
$0.07B |
$1.46B |
4.78% |
2016-09-30 |
$0.07B |
$1.42B |
4.90% |
2016-06-30 |
$0.04B |
$1.40B |
3.05% |
2016-03-31 |
$0.03B |
$1.33B |
2.53% |
2015-12-31 |
$0.04B |
$1.32B |
3.01% |
2015-09-30 |
$0.05B |
$1.33B |
3.47% |
2015-06-30 |
$0.06B |
$1.40B |
4.39% |
2015-03-31 |
$0.07B |
$1.39B |
5.48% |
2014-12-31 |
$0.07B |
$1.30B |
5.83% |
2014-09-30 |
$0.08B |
$1.20B |
6.34% |
2014-06-30 |
$0.10B |
$1.15B |
8.15% |
2014-03-31 |
$0.11B |
$1.16B |
8.71% |
2013-12-31 |
$0.10B |
$1.22B |
8.13% |
2013-09-30 |
$0.10B |
$1.23B |
8.29% |
2013-06-30 |
$0.07B |
$1.21B |
5.92% |
2013-03-31 |
$0.05B |
$1.21B |
4.45% |
2012-12-31 |
$0.05B |
$1.12B |
5.11% |
2012-09-30 |
$0.04B |
$0.91B |
4.72% |
2012-06-30 |
$0.04B |
$0.80B |
5.33% |
2012-03-31 |
$0.06B |
$0.76B |
8.86% |
2011-12-31 |
$0.05B |
$0.75B |
6.81% |
2011-09-30 |
$0.04B |
$0.69B |
6.44% |
2011-06-30 |
$0.03B |
$0.69B |
4.58% |
2011-03-31 |
$-0.00B |
$0.57B |
-0.37% |
2010-12-31 |
$0.01B |
$0.59B |
0.96% |
2010-09-30 |
$0.00B |
$0.50B |
0.20% |
2010-06-30 |
$0.02B |
$0.50B |
4.37% |
2010-03-31 |
$0.01B |
$0.50B |
2.78% |
2009-12-31 |
$0.01B |
$0.51B |
2.32% |
Sector |
Industry |
Market Cap |
Revenue |
Finance |
Finance - SBIC & Commercial |
$3.244B |
$0.461B |
Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
|